"Hauptstadtkongress 2024": Medios hosts symposium on 'Security of supply"

EQS-Media / 01.07.2024 / 09:32 CET/CEST

Press release

"Hauptstadtkongress 2024": Medios hosts symposium on "Security of supply"

Berlin, July 01, 2024 - Medios AG, a leading provider of Specialty Pharma in
Europe, was represented for the first time at the "Hauptstadtkongress"
(Capital Congress) in Berlin, which took place from June 26 to June 28, 2024
and was dedicated to the key topic of "Advancing the healthcare system".
With the symposium on the topic of "Security of supply for seriously ill
people - are all players pulling in the same direction?", Medios initiated a
multi-faceted dialog with various experts. The "Hauptstadtkongress" is the
most important congress event in the German healthcare market and attracts
more than 4,000 visitors every year.

Christoph Prußeit, Chief Innovation Officer of Medios AG, was joined by
Thomas Weigold (Country President Sandoz Germany & CEO Hexal AG), Dirk Düvel
(spokesman for the owners of "wir leben" pharmacies), Dr Klaus Gehring
(specialist physician in neurology and psychiatry) and Markus Teuber (VP
Partnerships, DasLab GmbH) to discuss the structural challenges of patient
care for seriously or chronically ill people in Germany. Due to the diverse
backgrounds of the panelists, the symposium offered a comprehensive insight
into the high relevance, current situation and development opportunities of
specialized care.

Christoph Prußeit, Chief Innovation Officer of Medios AG: "Healthcare in
Germany is facing significant challenges. Insolvent hospitals, a shortage of
qualified staff and the economic deficits of health insurance companies are
placing a heavy burden on the sector and are also affecting outpatient care.
In the Specialty Pharma sector in particular, it is our duty to ensure safe
and comprehensive care. To achieve this, optimal cooperation between all
players along the care chain - from the supplier to the dispensing pharmacy
- is essential."

Dirk Düvel, spokesman for the owners of "wir leben" pharmacies: "Specialized
care is associated with both high demands and a high level of
responsibility. In order to ensure comprehensive care, all stakeholders
involved need to work together effectively. In partnership with Medios, more
and more pharmacies in Germany can become involved in specialized care and
thus significantly improve the effectiveness and efficiency of care. This is
of enormous relevance, particularly in view of demographic change and the
associated increase in the number of serious illnesses."

Every year at the "Hauptstadtkongress", experts from various fields of
healthcare discuss important reform projects and set the course for the
modernization of the healthcare system. The "Hauptstadtkongress 2024", which
took place from June 26 to June 28 at hub27, Messe Berlin, focused on the
further development of the healthcare system. Three specialist congresses
were held under the roof of the "Hauptstadtkongress": the
"Gesundheitsmanagementkongress" (Health Management Congress), the
"Pflegemanagementkongress" (Nursing Management Congress) and the
"Ärzteforum" (Doctors' Forum). There was also the "Hauptstadtforum
Gesundheitspolitik" (Capital City Health Policy Forum), which also included
the Medios symposium.

Further information on the "Hauptstadtkongress 2024" is available here.

-------------------

About Medios AG
Medios is a leading provider of Specialty Pharma in Europe. With locations
in Germany, the Netherlands, Belgium and Spain, the company supports key
partners in the supply chain with innovative solutions and intelligent
services. Medios has focused on pioneering individualized medicine to make
the most innovative therapies available to everyone together with
pharmacies, specialist practices and pharmaceutical companies.

Medios AG is Germany's first listed specialty pharmaceutical company and is
listed on the Regulated Market of the Frankfurt Stock Exchange (Prime
Standard).

www.medios.ag

Contact
Claudia Nickolaus
Head of Investor & Public Relations, ESG Communications
Medios AG
Heidestraße 9 | 10557 Berlin
T +49 30 232 566 800
ir@medios.ag
www.medios.ag


End of Media Release

---------------------------------------------------------------------------

Issuer: Medios AG
Key word(s): Health

01.07.2024 CET/CEST Dissemination of a Press Release, transmitted by EQS
News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com

---------------------------------------------------------------------------

   Language:       English
   Company:        Medios AG
                   Heidestraße 9
                   10557 Berlin
                   Germany
   Phone:          +49 30 232 566 - 800
   Fax:            +49 30 232 566 - 801
   E-mail:         ir@medios.ag
   Internet:       www.medios.ag
   ISIN:           DE000A1MMCC8
   WKN:            A1MMCC
   Listed:         Regulated Market in Frankfurt (Prime Standard);
                   Regulated Unofficial Market in Berlin, Dusseldorf,
                   Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
   EQS News ID:    1936137

End of News EQS Media
---------------------------------------------------------------------------

1936137 01.07.2024 CET/CEST